Skip to content

German Epicardial Collateral CTO Registry

German Multicentre Registry to Evaluate the Technical Feasibilty of Epicardial Collateral Connections in CTO PCI

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04533633
Acronym
EPIC
Enrollment
500
Registered
2020-08-31
Start date
2018-01-01
Completion date
2022-12-31
Last updated
2020-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Total Occlusion, Coronary Artery Disease, Percutaneous Coronary Intervention

Brief summary

The EPIC registry is an observational multicentre registry evaluating the technical feasibility of retrograde CTO-PCI using epicardial collateral connections. It will evaluate the frequency, effectiveness, safety and outcomes of patients who underwent CTO-PCI using this approach. The EPIC registry retrieves data from CTO centres across Germany.

Detailed description

The EPIC registry is the first German-wide observational multicentre registry evaluating the technical feasibility, clinical success and safety of retrograde CTO-PCI using epicardial collateral connections. The EPIC registry retrieves data from CTO centres across Germany. All patients will be followed-up to 30 days after inclusion.

Interventions

PROCEDURERetrograde Percutaneous Coronary Intervention of Chronic Total Occlusion

Retrograde CTO-PCI using epicardial collateral connections

Sponsors

University Heart Center Freiburg - Bad Krozingen
CollaboratorOTHER
Universitätsmedizin Mannheim
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* All patients undergoing retrograde CTO-PCI using epicardial collateral connections during daily clinical practice.

Exclusion criteria

* None.

Design outcomes

Primary

MeasureTime frameDescription
Rate of technically successful retrograde CTO-PCI using epicaridal collaterals30 daysdefined as the rate of successful CTO-PCI with reestablished antegrade coronary flow (thrombolysis in myocardial infarction (TIMI) flow III) with less than residual stenosis of 50%.

Secondary

MeasureTime frameDescription
Rate of clinically successful retrograde CTO-PCI using epicaridal collaterals30 daysClinical success is defined as the rate of successful CTO-PCI by technical success without MACCE and without major periprocedural complications, including pericardial tamponade and contrast induced dialysis.
Rate of failed retrograde CTO-PCI using epicaridal collaterals30 daysis defined as the rate of CTO-PCI without technical success defined as residual stenosis \>50% (by visual estimation) and TIMI flow grade \<3 after CTO-PCI.

Countries

Germany

Contacts

Primary ContactMichael Behnes, Prof. Dr.
michael.behnes@umm.de+49 621 383 6239
Backup ContactKambis Mashayekhi, Dr.
Kambis.Mashayekhi@universitaets-herzzentrum.de+49 7633 402 2100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026